[go: up one dir, main page]

CA2261020A1 - Preparation of pichia methanolica auxotrophic mutants - Google Patents

Preparation of pichia methanolica auxotrophic mutants

Info

Publication number
CA2261020A1
CA2261020A1 CA002261020A CA2261020A CA2261020A1 CA 2261020 A1 CA2261020 A1 CA 2261020A1 CA 002261020 A CA002261020 A CA 002261020A CA 2261020 A CA2261020 A CA 2261020A CA 2261020 A1 CA2261020 A1 CA 2261020A1
Authority
CA
Canada
Prior art keywords
cells
culturing
culture medium
methanolica
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002261020A
Other languages
French (fr)
Other versions
CA2261020C (en
Inventor
Christopher K. Raymond
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/703,808 external-priority patent/US5736383A/en
Application filed by Individual filed Critical Individual
Publication of CA2261020A1 publication Critical patent/CA2261020A1/en
Application granted granted Critical
Publication of CA2261020C publication Critical patent/CA2261020C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Methods for preparing Pichia methanolica cells having auxotrophic mutations are disclosed. The methods comprise the steps of:
(a) exposing P. methanolica cells to mutagenizing conditions; (b) culturing the cells from step (a) in a rich medium to allow mutations to become established and replicated in at least a portion of the cells; (c) culturing the cells from step (b) in a culture medium deficient in assimilable nitrogen to deplete cellular nitrogen stores; (d) culturing the cells from step (c) in a defined culture medium comprising an inorganic nitrogen source and an amount of nystatin sufficient to kill growing P. methanolica cells to select for cells having a deficiency in a nutritional gene; and (e) culturing the selected cells from step (d) in a rich culture medium.
CA002261020A 1996-07-17 1997-07-14 Preparation of pichia methanolica auxotrophic mutants Expired - Fee Related CA2261020C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US68350096A 1996-07-17 1996-07-17
US60/042,910 1996-07-17
US08/703,808 1996-08-26
US08/703,808 US5736383A (en) 1996-08-26 1996-08-26 Preparation of Pichia methanolica auxotrophic mutants
PCT/US1997/012582 WO1998002536A2 (en) 1996-07-17 1997-07-14 Preparation of pichia methanolica auxotrophic mutants

Publications (2)

Publication Number Publication Date
CA2261020A1 true CA2261020A1 (en) 1998-01-22
CA2261020C CA2261020C (en) 2004-06-08

Family

ID=27103122

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002261020A Expired - Fee Related CA2261020C (en) 1996-07-17 1997-07-14 Preparation of pichia methanolica auxotrophic mutants

Country Status (6)

Country Link
JP (1) JP2002514049A (en)
CN (1) CN1238806A (en)
AU (1) AU708572B2 (en)
CA (1) CA2261020C (en)
IL (1) IL128072A0 (en)
WO (1) WO1998002536A2 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000017235A2 (en) 1998-09-23 2000-03-30 Zymogenetics, Inc. Cytokine receptor zalpha11
PL209535B1 (en) 1999-01-07 2011-09-30 Zymogenetics Inc SOLUBLE RECEPTOR BR43x2 AND METHODS OF USING THEM FOR THERAPY
US7833529B1 (en) 1999-01-07 2010-11-16 Zymogenetics, Inc. Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
IL145288A0 (en) 1999-03-09 2002-06-30 Zymogenetics Inc Novel cytokin zalpha11 ligand
DK1190056T3 (en) 1999-07-07 2007-07-30 Zymogenetics Inc Human cytokine receptor
AU2292601A (en) 1999-12-23 2001-07-03 Zymogenetics Inc. Novel cytokine zcyto18
AU2001273032A1 (en) 2000-06-26 2002-01-08 Zymogenetics Inc. Cytokine receptor zcytor17
AU2002238052A1 (en) 2001-02-20 2002-09-04 Zymogenetics, Inc. Antibodies that bind both bcma and taci
DE60234202D1 (en) 2001-05-24 2009-12-10 Zymogenetics Inc TACI-IMMUNOGLOBULIN FUSION PROTEINS
ES2411007T3 (en) 2001-10-10 2013-07-04 Novo Nordisk A/S Remodeling and glycoconjugation of peptides
EP1451322B1 (en) 2001-11-05 2009-09-30 ZymoGenetics, Inc. Il-21 antagonists
EP2338910B1 (en) 2002-01-18 2015-07-08 ZymoGenetics, Inc. Cytokine receptor Zcytor17 multimers
DK1476541T3 (en) 2002-01-18 2008-11-03 Zymogenetics Inc Cytokine (zcytor17 ligand)
EP1497415B1 (en) 2002-04-19 2010-12-29 ZymoGenetics, L.L.C. Methods for detection or modulation of the interaction of a cytokine receptor with its ligand
PL1615945T3 (en) 2003-04-09 2012-03-30 Ratiopharm Gmbh Glycopegylation methods and proteins/peptides produced by the methods
CA2834275A1 (en) 2004-08-02 2006-02-09 Basf Plant Science Gmbh Method for isolation of transcription termination sequences
CN100347287C (en) * 2004-09-30 2007-11-07 汪和睦 Recombinated multi shape ttansenula yeast, its structural method and application
AU2006212807A1 (en) 2005-02-08 2006-08-17 Zymogenetics, Inc. Anti-IL-20, anti-IL-22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation
EP3214095B1 (en) 2005-05-12 2019-12-11 ZymoGenetics, Inc. Compositions and methods for modulating immune responses
MX2008001661A (en) 2005-08-09 2008-04-07 Ares Trading Sa Methods for treating b-cell malignancies using taci-ig fusion molecule.
AU2006278227B2 (en) 2005-08-09 2011-10-20 Ares Trading S.A. Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules
WO2007038703A2 (en) 2005-09-28 2007-04-05 Zymogenetics, Inc Il-17a and il-17f antagonists and methods of using the same
US8784812B2 (en) 2006-05-15 2014-07-22 Zymogenetics, Inc. Methods for treating autoimmune diseases using a TACI-Ig fusion molecule
DK2602263T3 (en) 2007-11-21 2019-10-21 Roskilde Univ Polypeptides comprising an ice-binding activity
US8653020B2 (en) 2008-01-25 2014-02-18 Aarhus Universitet Selective exosite inhibition of PAPP-A activity against IGFBP-4
CA2746840A1 (en) 2008-12-16 2010-06-24 Novartis Ag Yeast display systems
US9771576B2 (en) 2012-02-01 2017-09-26 Synthetic Genomics, Inc. Materials and methods for the synthesis of error-minimized nucleic acid molecules
WO2014202089A2 (en) 2013-06-18 2014-12-24 Roskilde Universitet Variants of anti-freeze polypeptides
CN111157680B (en) * 2019-12-31 2021-10-26 北京辰安科技股份有限公司 Indoor volatile substance leakage tracing method and device
CN116064597B (en) * 2023-01-17 2024-04-26 北京大学 Directed evolution and darwinian adaptation in mammalian cells by autonomous replication of RNA

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2237039A1 (en) * 1995-11-09 1997-05-15 Zymogenetics, Inc. Production of gad65 in methylotrophic yeast

Also Published As

Publication number Publication date
JP2002514049A (en) 2002-05-14
IL128072A0 (en) 1999-11-30
CN1238806A (en) 1999-12-15
CA2261020C (en) 2004-06-08
AU708572B2 (en) 1999-08-05
AU3885697A (en) 1998-02-09
WO1998002536A2 (en) 1998-01-22
WO1998002536A3 (en) 1998-02-26

Similar Documents

Publication Publication Date Title
CA2261020A1 (en) Preparation of pichia methanolica auxotrophic mutants
AU1774000A (en) Methods for producing polypeptides in aspergillus mutant cells
CA2203936A1 (en) Boronic ester and acid compounds, synthesis and uses
IL158303A0 (en) Method for producing protein in an immortalized cell
AU1032597A (en) Process for preparing recombinant proteins in E. coli by means of high cell density fermentation
AU7213691A (en) Cell culture medium and method for preparing such medium
AU6532196A (en) Support for plant culture and method for plant growth
CA2146734A1 (en) Method for long term subculture of dermal papilla cells
WO2002033047A3 (en) In vitro embryo culture device
CA2200563A1 (en) Calcium free subtilisin mutants
CA2188165A1 (en) Methods for proliferating and differentiating b cells, and uses thereof
CA2115038A1 (en) A fermentation process for producing natamycin
AU8063798A (en) Secretory immunoglobulin produced by single cells and methods for making and using same
CA2333966A1 (en) Media for culturing animal cells and process for producing protein by using the same
CA2182522A1 (en) Process for the preparation of 4,6-dichloropyrimidine
EP0682106A3 (en) Liver parenchymal cells having clonal growth ability, method for obtaining same, method for culturing same, and culturing system of primary hepatocytes
AU7357896A (en) Deubiquitinating enzymes that regulate cell growth
IL81857A0 (en) In vitro method for producing infective bacterial spores and spore-containing insecticidal compositions
WO1998036636A3 (en) Method for generating embryogenic cell cultures for the production of bananas (musa spp.)
CA2278588A1 (en) Method for increasing the growth of plant cell cultures
CA2188434A1 (en) Method for Controlling Metallophosphate Precipitation in High Cell Density Fermentations
AU3876195A (en) Production of variant nisin
GR3034909T3 (en) Methods for producing protein C.
CA2337088A1 (en) Methods and constructs for protein expression
CA2182881A1 (en) Method for determining handover in a communications system

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed